Cibus, Inc. (CBUS) vs Coya Therapeutics, Inc. (COYA)

Cibus, Inc. and Coya Therapeutics, Inc. are both Biotechnology companies. Cibus, Inc. and Coya Therapeutics, Inc. are of similar size ($101.8M and $98.6M). Coya Therapeutics, Inc. grew revenue faster over the last twelve months: 108.4% against −10.3%. Coya Therapeutics, Inc. has the higher net margin (−270.2% vs −2,258.9%) and the lower return on invested capital (−15,230.9% vs 0.00%). Across the 16 metrics below, Coya Therapeutics, Inc. leads on 12 and Cibus, Inc. on 4.

Valuation

Metric CBUS COYA Biotechnology median
P/E n/m n/m 8.50
P/S 23.31 12.49 9.71
P/B 6.84 2.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 18.85 8.72 9.21
Earnings yield (125.00%) (25.06%) (33.15%)
Free cash flow yield (45.68%) (17.74%) (25.50%)

Profitability

Metric CBUS COYA Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (1,450.59%) (288.70%) 0.00%
Net margin (2,258.89%) (270.22%) 0.00%
Free cash flow margin (1,064.60%) (221.64%) 0.00%
Return on equity (219.97%) (60.54%) (56.36%)
Return on assets (29.77%) (53.66%) (48.04%)
Return on invested capital 0.00% (15,230.92%) 0.00%

Growth

Metric CBUS COYA Biotechnology median
Revenue growth (TTM) (10.30%) 108.35% 6.02%
EPS growth (last fiscal year) 74.33% (29.59%) 30.26%
Revenue growth, 5-year CAGR (31.34%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBUS COYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.62 13.40 4.72
Net debt to EBITDA (0.28) 2.08 0.96

Dividend

Metric CBUS COYA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CBUS COYA Biotechnology median
Market cap 98.59m 101.80m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack